Aims: The (cost-)effectiveness of a screening programme may be strongly influenced by the participation rate. The objective of this study was to compare participants' and non-participants' motives for the attendance decision as well as their overall preferences for participation in cardiovascular disease screening. Methods: This study sampled 1053 participants and 1006 non-participants from a screening trial and randomly allocated the participants to receive different levels of additional information about the screening programme. An ad hoc survey questionnaire about doubt and arguments in relation to the participation decision was given to participants and non-participants along with a contingent valuation task. Results: Among participants, 5% had doubt about participation and the most frequent argument was that they did not want the test result. Among non-participants, 40% would reconsider their non-participation decision after having received additional information while the remainder 60% stood by their decision and provided explicit arguments for it. After having received additional information the participants still valued the programme significantly higher than non-participants, but the difference was relatively small. Conclusions: Participants and non-participants in cardiovascular screening programmes seem to have different strengths of preferences, which signals that their behavioural choice is founded in rational thinking. Furthermore, it appears that additional information and a second reflection about the participation decision may affect a substantial proportion of non-participants to reverse their decision, a finding that should receive policy interest.
Introduction
The effectiveness and cost effectiveness of a screening programme may be strongly influenced by the participation rate not least because those who reject participation may do so due to reasons that are associated with a greater risk of disease [1, 2] . However, if non-participation reflects rational behaviour based on full information about the costs and benefits of the screening programme, declining to participate may be welfare enhancing. In order to decipher whether the patterns of participation reflect societal optimum, or whether efforts should be made to increase participation, it is important to gain knowledge of why individuals choose to accept or reject screening invitations.
The literature on what determines attendance rates and the individual participation decision appears to be limited and generally focused on cancer screening. In relation to colorectal cancer it has been shown that compensation may increase participation rates and that the propensity to participate is associated with socio-demographics, genetic predisposition, travel expenses, and subjective health status among others [3] . Another study in this disease area demonstrated that adoption of health protective behaviours is associated with a higher attendance whereas anxiety represents a strong barrier to participation [4] . Finally it has been suggested that low priority for screening is an important determinant for non-attendance [5] .
Screening for non-cancer-related diseases might be affected by different motives, in particular if there is less physical discomfort and/or emotional distress associated with the test but also if structural issues such as information, infrastructure, and local provision vary. An early study by Bryan et al., who surveyed individuals invited for abdominal aortic aneurysm screening suggested that private costs might play an important role for the participation decision [6] .
Neoclassical economic theory predicts that the individual will choose to participate in screening if the expected utility the individual gets from participation is greater than the expected disutility (i.e. if the benefits outweigh the costs) [7] . The benefits of screening relate to the reduction in uncertainty about future disease as well as the actual gain in health-related quality and length of life flowing from early detection of eventual disease. It has also been proposed that individuals gain utility from participation per se [8] . This could be due to receiving general information or minimising later regret, factors that are unrelated to the effectiveness of the programme. The personal costs of participation include the emotional distress associated with the articulation of the disease risk and prognosis, (expected) disutility of undergoing the test, plus the effort and expenses associated with travelling to and attending the test session, among others.
The perceived net benefit to the individual of engaging in screening depends on his preferences (i.e. how he weighs and values the arguments for and against participation). There is a history of measuring the strength of preferences for screening programmes by individuals' stated willingness to pay (WTP) [9] [10] [11] . This value is typically elicited by setting up a valuation task in a laboratory setting. The advantage of this approach is that valuations can be elicited for goods or services that are not sold on a market (or for which there is insufficient price variation). Furthermore, it allows for the presentation of information that may not be available on a "real" market. Valuations based on stated preferences thus, in some cases, may be more accurate than valuations based on revealed preferences if they are based on more information. The disadvantage of stated preference methods is that valuations may suffer from hypothetical bias, although this can be relieved if individuals are presented with realistic and relevant valuation tasks. This paper focuses on screening for cardiovascular disease, which seems to be an under-informed area in terms of the determinants of the participation decision and thus what can be initiated to improve the participation rate and in turn the effectiveness of screening programmes. A particular strength of the present study design is that individuals are surveyed after their behaviour has been observed, and that both participants and non-participants are surveyed about their decision uncertainty and preferences for screening. That the participants have made an actual choice prior to the survey is thought to minimise hypothetical bias as the questions posed in the stated preference survey are strongly linked to the actual choice scenario.
The objective of this study was to compare participants' and non-participants' motives for the attendance decision as well as their overall preferences for participation in cardiovascular disease screening.
Methods
The survey was conducted alongside a screening trial in about 25,000 men aged 65-75 years [12] . The aim of the trial, which is on going for long-term follow up, is to assess the effect of screening for abdominal aortic aneurysm, hypertension, and peripheral artery disease on disease-specific and overall mortality. If detected early these diseases can be moderated by medical prevention and/or surgical repair. The screening programme was provided free of charge.
The survey was designed to include samples of about 1000 participants and 1000 non-participants. Inclusion of consecutive cohorts was initiated in March 2010 and the target number for participants was acquired in April 2010 whereas the target number for non-participants was not met until December 2010. Participants were surveyed in the waiting room prior to the test while non-participants were surveyed by use of postal service about 2 weeks after their scheduled test. One reminder letter was sent to nonparticipants if they had not responded within 14 days. Figure 1 shows the flow chart for the survey.
The survey questionnaire was developed specifically for the present purpose during two rounds of pretesting. In the first round a first draft of the questionnaire was administered to three participants for think-aloud testing, which was followed by in-depth interview to reveal additional motives for participation and to reveal the respondents' understanding of the valuation task. This resulted in a second draft, which was tested on eight participants in a similar manner to the first round. The drafts were furthermore discussed with the two nurses running the screening programme focusing on terminology, logistic feasibility, and response rate impact.
The final questionnaire was structured in two parts. The first part included questions on doubt about and motives for (non-) participation and the second part provided information about the programme after which a valuation task was presented to the respondent. Only those participants who expressed doubt were asked about their reasons for doubting and only those non-participants who would reconsider their decision after being given additional information were asked to value the screening programme. The information given was based on random allocation of the surveyed individuals to three different information levels: no additional information (information level A), quantitative risk and effect information (information level B), and quantitative risk and effect information + information about the risk of unnecessary follow up (information level C). Since information level A reflects the level of information provided with the invitation to the screening programme, non-participants were only randomised to information levels B and C (as they had already expressed a WTP ≤ DKK 0 subject to information level A through their choice not to participate in the screening programme, which was free of charge).
After having received the information, respondents were asked to value the programme. In order to aid respondents in expressing their valuations, they were presented with a payment card listing 16 examples of bids from 0 to >10,000 DKK. Respondents could choose one of these bids as their maximum bid, but also had the option of providing an alternative bid. Respondents, who stated a zero-bid, were asked to justify their response to enable exclusion of potential protest bidders (i.e. bidders who state WTP = 0 for reasons that are irrelevant to the valuation task) in sensitivity analysis of the base-case results. A conservative choice of classifying zero-bids as reliable only for the two following arguments was made: (1) respondents stated that the programme had no value to them or (2) respondents stated that they could not afford to pay for the programme (thus indicating that money was better spent on other goods). The key components of the questionnaire are detailed in the supplemental material (available online).
The survey data was entered twice in database software to prevent errors. The data was hereafter merged with clinical records of attendees (similar data was not available for non-attendees) concerning age, smoking status, health-related quality of life, genetic predispositions, and the prevalence of selected morbidities. This data was collected during the screening session and therefore not available for non-participants.
For statistical analysis, both means with standard deviations (SD) and medians with interquartile ranges (IQR) were used. Comparison of proportions between groups was undertaken using cross-tabulation and Pearson's chi-squared test. Comparison of continuous parameters was undertaken using both Student's t-test on log-transformed parameters (when relevant due to skewness of the data) and the non-parametric Wilcoxon rank sum test. Standard OLS regression with heteroskedasticity-robust standard errors was used to test the explanatory role of the available respondent characteristics for participants (age, smoking, body mass index, bidding characteristics, health-related quality of life, genetic predisposition for the diseases screened for, use of medication related to cardiovascular disease, and morbidity) in relation to the stated WTP.
Results
The survey sampled 1053 participants and 1006 non-participants and response rates of 100% and 43%, respectively, were obtained. It should be noted that these very different rates could be explained by the different survey contexts: participants were given the questionnaire as part of the screening session, where the nurse checked that they had responded to at least basic questions, whereas non-participants were simply mailed a questionnaire.
Among participants, 5% had doubt about participation and the most frequent argument was that they did not want to receive the test result. This was also a main argument for non-participants, in addition to arguments such as participation being associated with too much effort and/or high transport expenses, or respondents having a low self-perceived risk (Table I) . That "transportation expenses" was objectively a higher barrier for non-participants was supported by analysis of the average distance between respondents' homes and the screening location; nonparticipants had a distance of 39 km, which was significantly longer than the 10 km of participants (p<0.001) and even of the 16 km of participants in doubt (p<0.001).
Non-participants were asked whether they would reconsider participation after being given additional information about the effect of screening. In Table II the subgroup of non-participants is further split according to that response with 40% expressing a willingness to reconsider. It was observed that those whose decision could be reversed, to a wider extent than those who were firm in their decision, decided not to participate for arguments that were not listed (p<0.001). Respondents were asked to provide details when reporting that "other reasons" played a role, but less than 15% did so. Those who would not reconsider participation more often reported that their (self-perceived) risk of cardiovascular disease was low (p=0.007) and that they did not want to receive the test result (p<0.001). Table III lists the results of the stated preference task, which was presented to participants as well as to non-participants who indicated that they were willing to reconsider their initial choice after being presented with additional information. For information level A (which included only the information which was provided in the invitation letter) the mean valuation was markedly higher for participants (DKK 815) than non-participants, who through their choice of not attending a programme in principle exhibited a WTP ≤ DKK 0. For information levels B and C, the WTP remained higher amongst participants (the statistical significance varied from p=0.001 to p=0.301 depending on the information level given and the choice of parametric versus non-parametric statistics).
The effect of additional information (and a second reflection about the participation decision) on nonparticipants' WTP appeared to be substantial. By turning down the standard invitation for screening, non-participants had already revealed that their baseline preferences corresponded to a WTP ≤ DKK 0. It was observed that their WTP increased to averages of DKK 657 and DKK 1227 for the information levels B and C, respectively. These values are significantly If participants reported to have had doubt about their participation decision, they were asked to give reasons. All non-participants were asked to provide arguments for not participating. Of the 328 participants who provided arguments for not participating, 29 did not respond to the question of whether they would reconsider participation after additional information. p-values refer to tests for differences between participants and non-participants (this test was not applicable for information level A, as nonparticipants were not randomised to information level A). The numbers of respondents with and without doubt do not necessarily sum to the total number of participants due to item non-responds to the doubt question. different from zero (p<0.0001 and p<0.0001), and thus significantly different from the baseline WTP based on revealed preferences. For participants no significant effect of information was observed. The survey data was linked with additional (clinical) data to enable multivariate analysis of what determines the strength of preference for screening (as indicated by respondents' WTP); this data was available for participants only. Table IV shows the results of regressing log-transformed WTP on respondent characteristics. Two variables stand out as highly significant: having had doubt about the participation decision is associated with lower WTP (p=0.003) and use of medication relating to cardiovascular disease is associated with higher WTP (p=0.007). The variables that are normally associated with lower socioeconomic groups and/or poor health all demonstrated negative associations with the WTP, although these results were not statistically significant.
Discussion
This study has shown that, when given additional information, up to 40% of non-participants in cardiovascular screening programmes can be affected to reverse their participation decision but also that the remainder proportion act seemingly rational and in accordance with their stated preferences. In particular, it was observed that participants in doubt were able to give specific reasons for their doubt whereas their nonparticipating counterparts were not as prone to giving specific reasons for their non-participation. It was furthermore observed that participants reported significantly higher WTP than non-participants and that the small subgroup of participants in doubt reported levels of WTP that were not significantly different from the WTP of non-participants who could be affected to reconsider their decision. Altogether, the results suggest that additional information and reflection may be an important means for improving the participation rate without changing or overriding individuals' preferences.
The main strength of the study is the attempt to survey both participants and non-participants as well as the fact that valuations are extracted subsequent to real decisions being made, thus reducing potential hypothetical bias. The respondents' thoughts regarding decision reversal, doubt, and valuations are therefore thought to be reflections that are as closely linked to real life decisions as possible when the context is healthcare services that are not marketed. The main weakness of the study is the low response rate of non-participants (43%), although this was an expected premise as early as in the design phase of the survey. Non-participants were asked to fill out the questionnaire in their homes and were sent one reminder in case of non-response. The current ethical guidelines for questionnaire-based surveys do not allow any further follow up. We cannot rule out that the non-response has given rise to selection bias in relation to the proportion of non-participants who would be willing to reconsider their decision not to participate in screening (40%).
The finding that 40% of non-participants would potentially alter their decision after additional information could have at least two explanations: (1) that information can be framed to affect participation decisions or (2) that the revealed choices (the initial decision not to participate) were not a result of utility optimising behaviour, but perhaps a result of cognitive errors, procrastination, or merely a non-decision. The literature sometimes refers to "bounded rationality" to describe the fact that individuals do not exercise rational choice for some forms of consumption, e.g. preventive health care [13] . This leads to economic inefficiency and the question therefore is whether paternalistic policies can or should be accepted in order to improve social welfare and health equity? There appears to be no previous studies relating to cardiovascular disease in this respect whereas examples of studies both for and against acceptance of the paternalistic approach in relation to mammography can be found [14, 15] . Given that it is considered acceptable to influence individual choice, there are different views on the optimal approach and whether it will in fact lead to welfare gains. Camerer et al. propose a form of socalled asymmetric paternalism due to the fact that individuals are heterogeneous with respect to how rationally they act [16] . In this view a possible means for improving participation rates in screening could be to provide a different type of information in a second invitation to non-participants. Glaeser, on the other hand, argues that such "soft" paternalism is in fact an "emotional tax on behaviour" that will not lead to welfare gains and should therefore be avoided [17] . The overall link between participation rates and social welfare thus seems to be not entirely straightforward and it should be noted that the optimal attendance rate is not necessarily 100% from a welfare economic perspective.
Another pertinent issue when discussing possible means of increasing participation rates is the distinction between what constitutes barriers to access (e.g. private costs, information, and the ability to make an informed choice) and what should be defined as true preferences of the individual, that ought to be respected. The present results have shed some light on this issue and identified one group of non-participants whose preferences appear robust and unaffected by information levels and another who demonstrate a high degree of uncertainty about the participation decision and whose stated preference (after a second reflection and additional information) deviated from their revealed choice. The latter group thus seems to require additional information to the standard invitation letter and the strong preferences they state after having received this information (WTP > DKK 0) indicate that it aids them to make a better choice.
The unanswered questions that arise from the present study includes the underlying behavioural patterns of the non-respondents and the specific form of information that exactly address their informational needs in a manner that does not overrule individual preferences. Qualitative research is clearly warranted in order to expand our understanding of these matters.
Conclusions
Participants and non-participants in cardiovascular screening programmes seem to have different strengths of preferences, which signals that their behavioural choice is founded in rational thinking. Furthermore, it appears that additional information and a second reflection about the participation decision may affect a substantial proportion of nonparticipants to reverse their decision, a fact that should receive policy interest. Future studies should however assess the ethical limits in relation to providing additional information, which can be seen as a paternalistic approach that in the worst case violates individuals' autonomy and in the best case improves social welfare and health equity.
